Prognostic significance of serum inflammation indexes in different Lauren classification of gastric cancer. (6th January 2021)

• Record Type: Journal Article
• Authors: Yin, Xin; Fang, Tianyi; Wang, Yimin; Wang, Yufei; zhang, Daoxu; Li, Chunfeng; Xue, Yingwei
• Is Part Of: Cancer medicine. Volume 10:Number 3(2021)
• Page Start: 1103
• Page End: 1119
• Publication Date: 2021-01-06
• Subjects: gastric cancer1 -- lauren classification2 -- nomogram6 -- platelet–lymphocyte ratio4 -- prognosis5 -- systemic immune‐inflammation index3; 616.994005
• DOI: 10.1002/cam4.3706
• Languages: English
• ISSNs: 2045-7634

Abstract

Abstract: Background: Inflammatory indexes are considered to be potential prognostic biomarkers for patients with gastric cancer (GC). However, little evidence has defined the prognostic significance of inflammatory indexes for GC with different Lauren classification. Methods: A total of 852 patients with GC were randomly selected consecutively into intestinal type and diffuse/mixed type groups. Group bias was reduced by propensity score matching. The cutoff values of inflammatory indexes were analyzed by receiver operating characteristic curve. The Kaplan–Meier method and log‐rank test were used to analyze the overall survival (OS). The chi‐square test was used to analyze the association between inflammatory indexes and clinical characteristics. The independent risk factor for prognosis in each group was analyzed by univariate and multivariate analyses based on logistic regression. The nomogram models were constructed by R studio. Results: Intestinal type GC patients ( p < 0.05) had a lower percentage of neutrophils in stage I, higher percentage of neutrophils and higher platelet count in stage Ⅲ ( p < 0.05). Systemic immune‐inflammation index (SII) ( p < 0.001), pTNM stage ( p < 0.001), and postoperative chemotherapy ( p = 0.002) were independent risk factors for prognosis in the intestinal type group. Platelet–lymphocyte ratio (PLR) ( p < 0.001) and pTNM stage ( p = 0.001) were independent risk factors for prognosis in the diffuse/mixed type group. The area under the curve of the nomogram model in predicting 5‐year prognosis in the intestinal type group and diffuse/mixed type group were 0.807 and 0.788, respectively. Conclusion: SII combined with postoperative chemotherapy and pTNM stage were used to construct a nomogram model to predict the prognosis of intestinal type GC. PLR combined with pTNM stage can be used to construct a nomogram model for diffuse/mixed type GC patients.